BP344

甲氧苄啶

British Pharmacopoeia (BP) Reference Standard

• 同義詞: 2,4-二氨基-5-(3,4,5-三甲氧基苄基)嘧啶, NSC 106568
• 經驗公式（希爾表示法）: C₁₄H₁₈N₄O₃
• CAS號碼: 738-70-5
• 分子量：: 290.32
• Beilstein: 625127
• EC號碼: 212-006-2
• MDL號碼: MFCD00036761
• 分類程式碼代碼: 41116107
• NACRES: NA.24

屬性

• 等級: pharmaceutical primary standard
• API 家族: trimethoprim
• 形狀: powder
• 儲存期限: limited shelf life, expiry date on the label
• 製造商／商標名: BP
• 應用: pharmaceutical; pharmaceutical small molecule
• 格式: neat
• 儲存溫度: 2-8°C
• SMILES 字串: COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC
• InChI: 1S/C14H18N4O3/c1-19-10-5-8(6-11(20-2)12(10)21-3)4-9-7-17-14(16)18-13(9)15/h5-7H,4H2,1-3H3,(H4,15,16,17,18)
• InChI 密鑰: IEDVJHCEMCRBQM-UHFFFAOYSA-N

描述

一般說明

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

應用

Trimethoprim BP Reference standard, intended for use in laboratory tests only as specifically prescribed in the British Pharmacopoeia.

Also used in monographs such as:

Paediatric Co-trimoxazole Oral Suspension

Co-trimazine Veterinary Oral Powder

Co-trimazine Tablets

Co-trimoxazole Dispersible Tablets

Co-trimoxazole Infusion

Co-trimazine Injection

Co-trimoxazole Tablets

Co-trimoxazole Oral Suspension

Trimethoprim Oral Suspension

主要作为抗细菌剂。 二氢叶酸还原酶抑制活性和原核酶选择性。

包裝

Unit quantity: 100 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity please visit British Pharmacopoeia

其他說明

Sales restrictions may apply.

安全資訊

• 象形圖: GHS08,GHS07
• 訊號詞: Warning
• 危險聲明: H302,H361d
• 防範說明: P202 - P264 - P280 - P301 + P312 - P308 + P313 - P405
• 危險分類: Acute Tox. 4 Oral - Repr. 2
• 儲存類別代碼: 11 - Combustible Solids
• 水污染物質分類（WGK）: WGK 3
• 閃點（°F）: Not applicable
• 閃點（°C）: Not applicable